
Biotech Firm Scribe Therapeutics Files for US Initial Public Offering
Scribe Therapeutics, a biotechnology company, has submitted a registration statement to go public on the Nasdaq Global Market under the ticker symbol 'SCTX'. The size and price of the offering have not yet been disclosed.







